Healthcare / Drug Manufacturers - Specialty & GenericUpdated 2026-05-10 22:07 UTC

CSE/GTII stock hub

CSE/GTII has a live ticker hub with the latest available market, valuation, profitability, growth, ownership, and risk indicators.

Browse stocks

CSE/GTIIis not in this month’s coverageGet our monthly research letter — no spam

Fair value midpoint

n/a

Fair value pending

Upside to midpoint

n/a

Based on latest report

Confidence

n/a

Data quality and model convergence

Market cap

2.5B

Canadian Securities Exchange

Market data

Live price

Current market quote for this ticker.

Current price

CSE/GTII

In the news

Latest news · CSE/GTII

Recent company headlines from major financial publishers.

—

Fetching the latest headlines.

—

Fetching the latest headlines.

—

Fetching the latest headlines.

Calendar

Next earnings

Upcoming earnings date and setup when available.

Upcoming

DateLoading

Window—

EPS estimate—

Revenue estimate—

Sector context

Where the current metrics sit

Percentiles come from the backend screener cohort cache for the ticker's country and sector.

Forward P/E78

P25 11P50 15.6P75 25.4

Trailing P/E15

P25 7.4P50 15.6P75 34.3

ROE6.6

P25 -121.5P50 -40.9P75 0.5

ROIC2.7

P25 -72.5P50 -16P75 1.4

Benchmarks - 1M

S&P 500n/a

Nasdaq Compositen/a

Dow Jones Industrial Averagen/a

Russell 2000n/a

Indicator catalog

All CSE/GTII market and fundamental indicators

A searchable catalog of the available market, valuation, profitability, growth, balance-sheet, ownership, and analyst metrics for this ticker.

Available fields

219

Groups with data

Currency

USD

Showing 219 of 219 available metrics for this ticker.

Profile and market data

Ticker identity, listing, currency, market cap, and source dates.

Metric	Value
Country	Canada
Country code	CA
Employees	5,000
Employees Change	200%
Employees Change Percent	4.17
Enterprise value	CAD 2.8B
Exchange	Canadian Securities Exchange
Financial currency	USD
First seen	2026-05-10
Industry	Drug Manufacturers - Specialty & Generic
Isin	CA39342L1085
Last refreshed	2026-05-10
Market cap	CAD 2.5B
Price	CAD 10.78
Price currency	CAD
Rev Per Employee	333,874.36x
Sector	Healthcare
Sic	2834
Symbol	cse/GTII
Website	https://www.gtigrows.com

Valuation

Multiples, yields, enterprise-value ratios, and valuation checks.

Metric	Value
Earnings Yield	6.83%
EV Earnings	16.48x
EV/EBIT	15.96x
EV/EBITDA	6.13x
EV/FCF	8.82x
EV/Sales	1.67x
FCF yield	12.75%
Forward P/E	78.04x
P/B ratio	0.94x
P/E ratio	15.05x
P/S ratio	1.48x
PE Ratio3 Y	38.43x
PE Ratio5 Y	54.01x

Profitability

Margins, returns on capital, cash conversion, and quality metrics.

Metric	Value
EBIT Margin	11.37%
EBITDA Margin	23.78%
FCF margin	18.93%
Gross margin	48.1%
Gross Profit	CAD 803M
Gross Profit Growth	-4.04%
Gross Profit Growth Q	0.26%
Gross Profit Growth3 Y	4.39%
Gross Profit Growth5 Y	9.7%
Net Income	CAD 169.2M
Net Income Growth	140.98%
Net Income Growth Q	85.37%
Net Income Growth Quarters	3%
Net Income Growth Years	3%
Net Income Growth5 Y	32.61%
Pretax Margin	23.98%
Profit Margin	10.14%
Profit Per Employee	CAD 33,848
Profitable Years	6
ROA	3.15
Roa5y	5.29
ROCE	5.15
ROE	6.63
Roe5y	3.98
ROIC	2.73
Roic5y	3.25

Growth

Revenue, earnings, cash-flow, and forward growth indicators.

Metric	Value
Cagr1y	29.59%
Cagr3y	-2.27%
Cagr5y	-22.3%
EPS Growth	147.4
EPS Growth Q	89.82
EPS Growth Quarters	3
EPS Growth Years	3
EPS Growth5 Y	30.28
FCF Growth	151.4%
FCF Growth Q	28.31%
FCF Growth5 Y	39.7%
OCF Growth	59.95%
OCF Growth Q	2.13%
OCF Growth3 Y	18.56%
OCF Growth5 Y	22.26%
Revenue Growth	4.83x
Revenue Growth Q	7.39x
Revenue Growth Quarters	11x
Revenue Growth Years	9x
Revenue Growth3 Y	5.33x
Revenue Growth5 Y	13.02x

Financial strength

Debt, cash, solvency, accounting-quality, and balance-sheet signals.

Metric	Value
Asset Turnover	CAD 0.44
Assets	CAD 4B
Cash	CAD 480.9M
Current Assets	CAD 921.2M
Current Liabilities	CAD 265.4M
Debt	CAD 785M
Debt EBITDA	CAD 1.67
Debt Equity	CAD 0.3
Debt FCF	CAD 2.48
Equity	CAD 2.6B
Interest Coverage	6.69
Liabilities	CAD 1.3B
Long Term Assets	CAD 3B
Long Term Liabilities	CAD 1B
Net Cash	CAD -304.1M
Net Cash By Market Cap	CAD -12.27
Net Debt EBITDA	CAD 0.77
Net Debt Equity	CAD 0.11
Net Debt FCF	CAD 0.96
Tangible Book Value	CAD 1.2B
Tangible Book Value Per Share	CAD 5.42
WACC	7.47

Liquidity

Current-asset coverage and working-capital efficiency metrics.

Metric	Value
Current ratio	3.47
Inventory Turnover	3.82
Net Working Capital	CAD 248.1M
Quick ratio	2.04
Working Capital	CAD 669.6M
Working Capital Turnover	CAD 4.53

Dividends and buybacks

Dividend yield, payout, buybacks, and shareholder-yield indicators.

Metric	Value
Buyback Yield	2.23%
Payout Ratio	0.09%

Performance and technicals

Returns, volatility, beta, momentum, RSI, and moving-average context.

Metric	Value
1Y total return	29.57%
200-day SMA	10.08
3Y total return	-6.67%
50-day SMA	9.47
50-day SMA vs 200-day SMA	50under200
5Y total return	-71.68%
All Time High	49.66
All Time High Change	-78.29%
All Time High Date	2021-02-10
All Time Low	5.05
All Time Low Change	113.47%
All Time Low Date	2020-03-16
ATR	0.72
Beta	0.93
Beta1y	1.01
Beta2y	1.02
Ch YTD	-2.18
High	11.1
High52	14.39
High52 Date	2025-12-17
High52ch	-25.09%
Low	10.7
Low52	6.54
Low52 Date	2025-06-24
Low52ch	64.83%
Ma50ch	13.83%
Price vs 200-day SMA	6.94%
RSI	56.8
RSI Monthly	49.17
RSI Weekly	57.28
Sharpe ratio	0.68x
Sortino ratio	1.33
Total Return	2.23%
Tr YTD	-2.18
Tr1m	18.33%
Tr1w	-0.83%
Tr3m	9%

Analyst estimates

Ratings, targets, revisions, and forward estimate fields.

Metric	Value
Operating Income	CAD 189.8M
Operating Income Growth	-30.88
Operating Income Growth Q	-4.11
Operating Income Growth3 Y	-12.17
Operating Income Growth5 Y	-1.96
Operating margin	11.37

Ownership and float

Institutional, insider, float, short-interest, and share-count fields.

Metric	Value
Float	182,004,172%
Net Borrowing	50,362,122
Shares Insiders	10.63%
Shares Institutions	4.36%
Shares Out	226,383,429
Shares Qo Q	-1.09%
Shares Yo Y	-2.23%

Other indicators

Additional ticker metrics that do not fit the primary research groupings yet.

Metric	Value
Adjusted FCF	CAD 253M
Average Volume	305,119.2x
Bv Per Share	11.7
CAPEX	CAD -97.8M
Ch1m	18.33
Ch1w	-0.83
Ch1y	29.57
Ch3m	9
Ch3y	-6.67
Ch5y	-71.68
Ch6m	9.78
Change	-2.62%
Change From Open	-2.18
Close	11.07
Days Gap	-0.45
Depreciation Amortization	202,939,939.6
Dollar Volume	1,782,785.6
Earnings Date	2026-05-06
EBIT	CAD 189.8M
EBITDA	CAD 397M
EPS	CAD 0.73
F Score	5
FCF	CAD 316.1M
FCF EV Yield	11.33x
FCF Per Share	CAD 1.4
Financing CF	-56,505,809
Fiscal Year End	December
Founded	2,014
Goodwill	808,970,976.2
Graham Number	13.83734
Graham Upside	28.36
Income Tax	CAD 229M
Investing CF	-168,054,565
Is Primary Listing	1
Last Earnings Date	2026-05-06
Last Report Date	2026-03-31
Lynch Fair Value	CAD 18.19
Lynch Upside	68.74
Ma150	9.89
Ma150ch	9.05%
Ma20	10.29
Ma20ch	4.79%
Net CF	189,320,492
Open	11.02
P FCF Ratio	7.84
P OCF Ratio	5.99
Position In Range	20
Ppne	1,263,464,520.4
Price Date	2026-05-08
Price EBITDA	CAD 6.24
Ptbv Ratio	2.02
Relative Volume	0.54x
Revenue	1,669,371,788x
SBC By Revenue	3.77x
Share Based Comp	63,010,516
Tax By Revenue	13.72x
Tax Rate	57.21%
Tr6m	9.78%
Volume	165,379

Fast facts

Decision checkpoints

A compact product layer over the same report payload.

Risk gate

n/a

Named kill scenarios are reviewed before any bullish rating can stand.

Moat score

n/a

Business quality stays separate from stock attractiveness.

Forward P/E

n/a

Valuation uses the full report model stack, not a single multiple.

Next action

Research pending

Final action steps are kept in the recommendation tab.

Income

Does CSE/GTII pay a dividend?

Capital-return profile for this ticker.

Performance

CSE/GTII stock returns vs the market

Total return (incl. dividends) compared to S&P 500.

Ownership

Who owns CSE/GTII?

Insider, institutional, and short-interest positioning.

Institutional ownership

+4.4%

Share of float held by funds and institutions

Insider ownership

+10.6%

Stake held by company insiders. Higher generally signals alignment.

Short interest

n/a

Float sold short by bearish positioning

Y/Y dilution

-2.2%

Negative means the company is buying back shares.

Technical

CSE/GTII momentum and risk profile

RSI, moving-average stack, beta, and risk-adjusted return.

RSI (14)

56.8

Neutral momentum band

Price vs 200-day MA

+6.9%

50/200-day relationship not available

Beta (5Y)

0.93

Moves roughly with the market

Sharpe ratio

0.68

Risk-adjusted return — higher is better; >1.0 is solid.

Questions

About CSE/GTII

Hub-level FAQ points readers to the deeper analysis pages.

What is the current cse/GTII stock rating?

cse/GTII is currently shown with the latest rating in the latest report. The hub links directly to the full analysis surface where the rating, fair-value bridge, risks, and scorecard are documented together.

Where can I read the full cse/GTII analysis?

The full report lives at /stocks/cse/GTII/analysis. The bare ticker page is a product hub that summarizes the latest read and sends readers into the relocated analysis tabs without making the analysis surface depend on the hub.

What fair-value range is used for cse/GTII?

The latest report frames cse/GTII around the latest fair-value range. Treat that range as the entry point, then check the valuation, sensitivity, and bear-case tabs before making an investment decision.

How often is the cse/GTII page updated?

The hub updates with the latest published stock report and live backend market data. The analysis pages remain reachable under /analysis, so a hub rollback does not remove the report reader.